Inhibitory Effect of (-)-myrtenol alone and in combination with antifungal agents on Candida spp.

Authors

DOI:

https://doi.org/10.33448/rsd-v10i15.22434

Keywords:

Monoterpenes; Antifungal activity; Natural products; Alternative therapy.

Abstract

The aim of this study was to examine the effects of (-)-myrtenol alone and combined with antifungal agents against Candida spp. The Minimum Inhibitory Concentration (MIC) and Minimum Fungicidal Concentration of (-)-myrtenol and fluconazole against C. albicans and C. parapsilosis strains was obtained using CLSI guidelines. Combination of (-)-myrtenol with antifungal drugs was determined by checkboard test. The (-) myrtenol showed MIC ranging from 256 to 512 µg/mL against both species assay. And the MFC was 512 µg/mL, demonstrated nature fungicidal (MFC/MIC < 4). In addition, combination of antifungal agents (amphotericin B and fluconazole) and (-) myrtenol showed synergistic and additive effects on strains assays. Based on these results, the present study demonstrates that (-) myrtenol showed strong fungicide activity against Candida spp. In addition, Combination of antifungal agents and (-) myrtenol reduces the effective concentrations of both the agents with synergistic to additive effects. Therefore, (-) myrtenol has potential to be developed into an antifungal agent.

Author Biographies

Bruno Bezerra Cavalcanti, Federal University of Paraiba

Health Sciences Center, Federal University of Paraıba, João Pessoa 58051-970, PB, Brazil

Hermes Diniz Neto, Federal University of Paraiba

Health Sciences Center, Federal University of Paraıba, João Pessoa 58051-970, PB, Brazil.

Walicyranison Plinio da Silva-Rocha, Federal University of Paraiba

Pharmaceutical Sciences Department, Health Sciences Center, Federal University of Paraiba, Campus I, João Pessoa, PB, Brazil

Edeltrudes de Oliveira Lima, Federal University of Paraiba

Pharmaceutical Sciences Department, Health Sciences Center, Federal University of Paraiba, Campus I, João Pessoa, PB, Brazil

José Maria Barbosa Filho, Federal University of Paraiba

Pharmaceutical Sciences Department, Health Sciences Center, Federal University of Paraiba, Campus I, João Pessoa, PB, Brazil.

Ricardo Dias de Castro, Federal University of Paraiba

Department of Clinical and Social Dentistry, Federal University of Paraıba, Campus I, João Pessoa, PB, Brazil

Fabio Correia Sampaio, Federal University of Paraiba

Department of Clinical and Social Dentistry, Federal University of Paraıba, Campus I, João Pessoa, PB, Brazil

References

Ahmad, A., Wani, M. Y., Khan, A., Manzoor, N., & Molepo, J. (2015). Synergistic Interactions of Eugenol-tosylate and Its Congeners with Fluconazole against Candida albicans. PLOS ONE, 10(12), e0145053. https://doi.org/10.1371/JOURNAL.PONE.0145053

Ben-Ami, R. (2018). Treatment of Invasive Candidiasis: A Narrative Review. Journal of Fungi 2018, Vol. 4, Page 97, 4(3), 97. https://doi.org/10.3390/JOF4030097

Bhattacharya, S., Sae-Tia, S., & Fries, B. C. (2020). Candidiasis and Mechanisms of Antifungal Resistance. Antibiotics 2020, Vol. 9, Page 312, 9(6), 312. https://doi.org/10.3390/ANTIBIOTICS9060312

Chang, Y. L., Yu, S. J., Heitman, J., Wellington, M., & Chen, Y. L. (2017). New facets of antifungal therapy, 8(2), 222–236. https://doi.org/10.1080/21505594.2016.1257457

Clinical and Laboratory Standards Institute. (2008). Reference method for broth dilution antifungal susceptibility testing of yeasts : approved standard (Vol. 22). Clinical and Laboratory Standards Institute.

Cordeiro, L., Figueiredo, P., Souza, H., Sousa, A., Andrade-Júnior, F., Barbosa-Filho, J., & Lima, E. (2020). Antibacterial and Antibiofilm Activity of Myrtenol against Staphylococcus aureus. Pharmaceuticals (Basel, Switzerland), 13(6), 1–12. https://doi.org/10.3390/PH13060133

Dąbrowska, M., Zielińska-Bliźniewska, H., Kwiatkowski, P., Łopusiewicz, Ł., Pruss, A., Kostek, M., Kochan, E., & Sienkiewicz, M. (2021). Inhibitory Effect of Eugenol and trans-Anethole Alone and in Combination with Antifungal Medicines on Candida albicans Clinical Isolates. Chemistry & Biodiversity, 18(5), e2000843. https://doi.org/10.1002/CBDV.202000843

Fuentefria, A. M., Pippi, B., Lana, D. F. D., Donato, K. K., & Andrade, S. F. de. (2018). Antifungals discovery: an insight into new strategies to combat antifungal resistance. Letters in Applied Microbiology, 66(1), 2–13. https://doi.org/10.1111/LAM.12820

Gomes, B., Neto, B., Lopes, E., Cunha, F., Araújo, A., Wanderley, C., Wong, D., Júnior, R., Ribeiro, R., Sousa, D., Medeiros, J., RCM, O., & FA, O. (2017). Anti-inflammatory effect of the monoterpene myrtenol is dependent on the direct modulation of neutrophil migration and oxidative stress. Chemico-Biological Interactions, 273, 73–81. https://doi.org/10.1016/J.CBI.2017.05.019

Guerra, F. Q. S., Araújo, R. S. A., Sousa, J. P., Silva, V. A., Pereira, F. O., Mendonça-Junior, F. J. B., Barbosa-Filho, J. M., Pereira, J. A., & Lima, E. O. (2018). A new coumarin derivative, 4-acetatecoumarin, with antifungal activity and association study against Aspergillus spp. Brazilian Journal of Microbiology, 49(2). https://doi.org/10.1016/j.bjm.2017.06.009

Huang, S., Tan, Z., Cai, J., Wang, Z., & Tian, Y. (2021). Myrtenol improves brain damage and promotes angiogenesis in rats with cerebral infarction by activating the ERK1/2 signalling pathway. Pharmaceutical Biology, 59(1), 584–593. https://doi.org/10.1080/13880209.2021.1917626

Jeffery-Smith, A., Taori, S. K., Schelenz, S., Jeffery, K., Johnson, E. M., Borman, A., Manuel, R., & Browna, C. S. (2018). Candida auris: A review of the literature. Clinical Microbiology Reviews, 31(1). https://doi.org/10.1128/CMR.00029-17

Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2020). Antifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond. Chemical Reviews, 121(6), 3390–3411. https://doi.org/10.1021/ACS.CHEMREV.0C00199

Nikitina, L. E., Lisovskaya, S. A., Startseva, V. A., Frolova, L. L., Kutchin, A. v., Shevchenko, O. G., Ostolopovskaya, O. v., Pavelyev, R. S., Khelkhal, M. A., Gilfanov, I. R., Fedyunina, I. v., Khaliullin, R. R., Akhverdiev, R. F., Gerasimov, A. v., Abzaldinova, E. v., & Izmailov, A. G. (2021). Biological Activity of Bicyclic Monoterpene Alcohols. BioNanoScience 2021, 1, 1–7. https://doi.org/10.1007/S12668-021-00912-8

Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018). Invasive candidiasis. Nature Reviews Disease Primers 2018 4:1, 4(1), 1–20. https://doi.org/10.1038/nrdp.2018.26

Perea, S., Gonzalez, G., Fothergill, A. W., Sutton, D. A., & Rinaldi, M. G. (2002). In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles. Journal of Clinical Microbiology, 40(5), 1831–1833. https://doi.org/10.1128/JCM.40.5.1831-1833.2002

Sartoratto, A., Machado, A. L. M., Delarmelina, C., Figueira, G. M., Duarte, M. C. T., & Rehder, V. L. G. (2004). Composition and antimicrobial activity of essential oils from aromatic plants used in Brazil. Brazilian Journal of Microbiology, 35(4), 275–280. https://doi.org/10.1590/S1517-83822004000300001

Shaban, S., Patel, M., & Ahmad, A. (2020). Improved efficacy of antifungal drugs in combination with monoterpene phenols against Candida auris. Scientific Reports 2020 10:1, 10(1), 1–8. https://doi.org/10.1038/s41598-020-58203-3

Siddiqui, Z. N., Farooq, F., Musthafa, T. N. M., Ahmad, A., & Khan, A. U. (2013). Synthesis, characterization and antimicrobial evaluation of novel halopyrazole derivatives. Journal of Saudi Chemical Society, 17(2), 237–243. https://doi.org/10.1016/J.JSCS.2011.03.016

Tacconi, L. (2018). Scientific Methodology *. In Biodiversity and Ecological Economics. https://doi.org/10.4324/9781315096308-2

Viana, A. F. S. C., Lopes, M. T. P., Oliveira, F. T. B., Nunes, P. I. G., Santos, V. G., Braga, A. D., Silva, A. C. A., Sousa, D. P., Viana, D. A., Rao, V. S., Oliveira, R. de C. M., & Santos, F. A. (2019). (−)-Myrtenol accelerates healing of acetic acid-induced gastric ulcers in rats and in human gastric adenocarcinoma cells. European Journal of Pharmacology, 854, 139–148. https://doi.org/10.1016/J.EJPHAR.2019.04.025

Wall, G., & Lopez-Ribot, J. L. (2020). Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy. Antibiotics 2020, Vol. 9, Page 445, 9(8), 445. https://doi.org/10.3390/ANTIBIOTICS9080445

Downloads

Published

17/11/2021

How to Cite

CAVALCANTI, B. B.; DINIZ NETO, H. .; SILVA-ROCHA, W. P. da .; LIMA, E. de O.; BARBOSA FILHO, J. M.; CASTRO, R. D. de; SAMPAIO, F. C. .; GUERRA, F. Q. S. . Inhibitory Effect of (-)-myrtenol alone and in combination with antifungal agents on Candida spp. Research, Society and Development, [S. l.], v. 10, n. 15, p. e35101522434, 2021. DOI: 10.33448/rsd-v10i15.22434. Disponível em: https://www.rsdjournal.org/index.php/rsd/article/view/22434. Acesso em: 20 apr. 2024.

Issue

Section

Health Sciences